Once an investigator has been shown beyond all reasonable shadow of doubt to have submitted fraudulent data to a pharmaceutical company or contract house, it is essential in the interests of the public, the profession, and the industry that that doctor should be dealt with. In the UK this is usually by referral to the General Medical Council (GMC) for possible consideration by the professional conduct committee. Alternatively, the doctor may be prosecuted for the criminal offence of deception. Chapter 16 by Jay deals with the GMC procedure and other legal issues.
The following cases are typical examples of those submitted by pharmaceutical companies in conjunction with the ABPI to the General Medical Council.
Was this article helpful?